Back to Journals » Hepatic Medicine: Evidence and Research » Volume 1

Weekly cisplatin may reverse liver dysfunction and jaundice caused by diffuse liver metastases of solid tumors

Authors Gabrovska M, Geurs F, Ponette S, Ponette J, Bulte K, Derveaux L, Kempeneers I

Published 30 October 2009 Volume 2009:1 Pages 9—12

DOI https://doi.org/10.2147/HMER.S7574

Review by Single anonymous peer review

Peer reviewer comments 3


M Gabrovska,1 F Geurs,1 S Ponette,2 J Ponette,2 K Bulte,2 L Derveaux,3 I Kempeneers4

1Depts of Medical Oncology, 2Gastroenterology, 3Pneumology and 4Surgery, Regionaal Ziekenhuis Sint Maria, Halle, Belgium

Abstract: Few data are available on patient management in jaundice caused by liver metastases of solid tumors (nonbreast and noncolon origin). We report the first patient series consecutively treated with cisplatin weekly in patients with severe jaundice and liver failure due to underlying metastatic neoplasms. In 4 out of 8 cases, liver function tests were reversed and jaundice disappeared, permitting subsequent standard chemotherapy. The other 4 patients died 3 to 5 weeks after admission, illustrating the extent and severity of the underlying neoplasm.

Keywords: liver failure, jaundice, metastases, chemotherapy, cisplatin

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]